amsacrine has been researched along with Rectal Neoplasms in 2 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Rectal Neoplasms: Tumors or cancer of the RECTUM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Omura, GA | 1 |
Bartolucci, AA | 1 |
Lessner, HE | 1 |
Hill, GJ | 1 |
Valdivieso, M | 1 |
Stroehlein, JR | 1 |
Bedikian, AY | 1 |
Karlin, DA | 1 |
Legha, SS | 1 |
Bennetts, RW | 1 |
Bodey, GP | 1 |
2 other studies available for amsacrine and Rectal Neoplasms
Article | Year |
---|---|
Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial.
Topics: Aminoacridines; Amsacrine; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Gastro | 1984 |
Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
Topics: Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Bone Marrow; Colonic Neoplasms; Drug | 1983 |